Leonetti & Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-51,815
Closed -$7.56M 47
2017
Q3
$7.56M Buy
+51,815
New +$7.06M 2.01% 15
2017
Q2
Sell
-67,700
Closed -$8.42M 45
2017
Q1
$8.42M Buy
+67,700
New +$8.1M 2.45% 11
2016
Q1
Sell
-69,500
Closed -$8.32M 45
2015
Q4
$8.32M Sell
69,500
-800
-1% -$92.6K 2.49% 15
2015
Q3
$7.6M Buy
70,300
+800
+1% +$99.3K 2.4% 12
2015
Q2
$8.04M Sell
69,500
-360
-0.5% -$41.2K 2.3% 12
2015
Q1
$8.05M Buy
69,860
+900
+1% +$108K 2.4% 13
2014
Q4
$7.71M Sell
68,960
-2,150
-3% -$227K 2.41% 13
2014
Q3
$6.74M Buy
71,110
+100
+0.1% +$9.02K 2.16% 15
2014
Q2
$6.1M Sell
71,010
-1,150
-2% -$87.5K 2.09% 16
2014
Q1
$5.04M Sell
72,160
-72,854
-50% -$5.77M 1.7% 19
2013
Q4
$12.3M Buy
145,014
+1,814
+1% +$144K 4.25% 7
2013
Q3
$11M Sell
143,200
-3,500
-2% -$245K 4.02% 9
2013
Q2
$8.58M Buy
+146,700
New +$8.83M 3.28% 9

Other funds holding CELG

Leonetti & Associates's CELG Position: Q4 2017 in Review

Leonetti & Associates sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 51,815 shares — an estimated $7.56M sold.

Leonetti & Associates first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $12.3M in Q4 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Leonetti & Associates reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Leonetti & Associates sold 51,815 Celgene Corp shares in Q4 2017, an estimated $7.56M.
  • Leonetti & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
  • Leonetti & Associates's Celgene Corp position peaked at $12.3M in Q4 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Leonetti & Associates's 13F filing for Q4 2017, filed 15 Feb 2018.